The S&P 500 fell 0.42% to 4,122.47, the Nasdaq Composite dropped 1.19% to 12,493.93 and the Dow Jones Industrial Average shed 58.13 points, or 0.18%, to close at 32,774.41
US stocks fell on Tuesday as investors navigated a batch of disappointing company reports ahead of a key inflation reading.
The S&P 500 fell 0.42% to 4,122.47, while the Nasdaq Composite dropped 1.19% to 12,493.93. The Dow Jones Industrial Average shed 58.13 points, or 0.18%, to close at 32,774.41.
The declines came after memory chipmaker Micron warned that revenue may fall short of its prior guidance because of ‘macroeconomic factors and supply chain constraints.’ The stock fell more than 3%.
It’s been a rough week for chipmakers. On Monday, weaker-than-expected revenue guidance from Nvidia weighed on the group, and those stocks extended their losses on Tuesday.
These are two big players that I think investors thought were in a better position to navigate through some of these recent supply chain issues. I think there’s concern that this is really going to weigh on tech, said Ed Moya, senior market analyst at Oanda.
The S&P 500 has climbed for three straight weeks, but earnings season has featured demand warnings from executives of major companies. Investors are watching closely to determine how the Federal Reserve’s fight against inflation is rippling through the economy.
Everything that we’re getting is (showing) that inflation is having a much harder impact on corporate America outlooks, and that’s why I think this market is going to be difficult to continue to buy equities, Moya added.
Outside of chips, a pair of Nasdaq-listed stocks also got hit. Novavax slumped nearly 30% after slashing full-year revenue guidance because of poor demand for its Covid vaccines. Upstart declined more than 11% after the consumer lending company reported second quarter results that missed both profit and revenue expectations.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.